About this trial
Acute pancreatitis is a rare complication after percutaneous mechanical thrombectomy in treatment of thrombotic disorders. The objectives of this study include: (1) Determine the incidence and severity of acute pancreatitis after percutaneous mechanical thrombectomy; (2) Identify patient/procedural risk factors; (3) Evaluate clinical outcomes; (4) Develop a diagnosis and treatment pathway.
Eligibility criteria
Qualifiers
Patients over 18 years old;
Patients with thrombotic peripheral vascular diseases treated by percutaneous mechanical thrombectomy;
Patients developed acute pancreatitis within 14 days after percutaneous mechanical thrombectomy;
Patients with written informed consent.
Disqualifiers
Patients with acute pancreatitis attributed to other confirmed causes;
Patients unable or unwilling to participate in the study.
Trial design
Treatments tested in this trial
- Not listed